The problem with CAR-T therapies are that they are very expensive and put the patient through extensive procedures (along with being dependent on the engineering of blood), other epigenetic treatments that utilize small molecule inhibitors can do this is in pill form using the body's own resources and are far safer than CAR-T.
The problem with CAR-T therapies are that they are very expensive and put the patient through extensive procedures (along with being dependent on the engineering of blood), other epigenetic treatments that utilize small molecule inhibitors can do this is in pill form using the body's own resources and are far safer than CAR-T.
The problem with CAR-T therapies are that they are very expensive and put the patient through extensive procedures (along with being dependent on the engineering of blood), other epigenetic treatments that utilize small molecule inhibitors can do this is in pill form using the body's own resources and are far safer than CAR-T.